Searchable abstracts of presentations at key conferences in endocrinology

ea0004p73 | Reproduction | SFE2002

Co-expression of GnRH-1 and NELF peptides in human olfactory neurons

Gonzalez-Martinez D , MacColl G , Vannelli G , Bouloux P

IntroductionThe main population of GnRH-1 neurons that control activity of the HPG axis in primates originate in the peripheral olfactory system. Recently, in vitro primary cell cultures from human fetal olfactory epithelium, named FNC-B4, have been shown to express GnRH-1 and are likely to be the precursor of the adult-like GnRH-1 system distribution in the CNS. A number of external and cell-autonomous factors are known to control migration of these spe...

ea0002p67 | Neuroendocrinology | SFE2001

NELF, Leptin and NPY receptors are expressed by human olfactory neuroepithelial cells

MacColl G , Sinclair L , Vannelli G , Bouloux P

IntroductionIn higher vertebrates, the main population of forebrain GnRH1 neurons originate in the embryonic olfactory placode. Early migration of GnRH neurons in mice - from the nasal placode into the nasal mesenchyme - depends on NELF (nasal embryonic LHRH factor). Furthermore, migratory GnRH cells express the leptin receptor. The precise role(s) of leptin during neuroendocrine GnRH development are unknown but it may combine with Neuropeptide Y (NPY) t...

ea0029p1050 | Male Reproduction | ICEECE2012

Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats

Morelli A. , Sarchielli E. , Comeglio P. , Filippi S. , Mancina R. , Gacci M. , Vignozzi L. , Carini M. , Vannelli G. , Maggi M.

Introduction: In humans, prostate PDE5 expression was prominently localized in the endothelial and smooth muscle cells of the vascular bed, suggesting a possible action of PDE5 inhibitors on prostate blood flow.Aim: To investigate PDE5 expression in human and rat lower urinary tract (LUT) tissues and determine the effects of PDE5 inhibition with tadalafil on prostatic blood perfusion.Main outcome measures: Human vesicular-deferenti...

ea0026p349 | Steroid metabolism | ECE2011

Beneficial effects of testosterone supplementation on prostatitis-like alterations in an animal model of metabolic syndrome

Morelli A , Filippi S , Vignozzi L , Comeglio P , Sarchielli E , Maneschi E , Cellai I , Vannelli G B , Maggi M

Introduction: Several studies suggested a direct relationship between metabolic syndrome (MetS) and increased risk of benign prostatic hyperplasia (BPH). An inflammatory component, mainly mediated by IL-8, has been proposed as the primary link between MetS and BPH pathogenesis. MetS, is often associated with testosterone (T) deficiency and an imbalance between the androgen and estrogen ratio characterizes BPH patients.Methods: We investigated the effects...

ea0026p350 | Steroid metabolism | ECE2011

Testosterone supplementation improves adipose tissue function in an animal model of metabolic syndrome

Morelli A , Maneschi E , Vignozzi L , Filippi S , Marchetta M , Mazzanti B , Calcagno A , Comeglio P , Cellai I , Vannelli G B , Maggi M

Introduction: Adipose tissue dysfunction is associated to metabolic syndrome (MetS), a clustering of cardio-metaboilic risk factors, including hypogonadism. We recently demonstrated that T supplementation was able to ameliorate the metabolic profile and reduce visceral fat accumulation in high-fat diet (HFD)-induced rabbit model of MetS.Methods: We evaluated the differentiation capacity of preadipocytes (rPAD) obtained from visceral fat of the following ...

ea0029p1207 | Obesity | ICEECE2012

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

Vignozzi L. , Morelli A. , Sarchielli E. , Comeglio P. , Filippi S. , Cellai I. , Maneschi E. , Serni S. , Gacci M. , Carini M. , Piccinni M. , Saad F. , Adorini L. , Vannelli G. , Maggi M.

Metabolic syndrome (MetS) and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) are often associated. One of their common denominators is hypogonadism. However, testosterone supplementation is limited by concerns for potential prostatic side effects. The objective was to determine whether MetS-associated prostate alterations are prevented by testosterone supplementation. We used a previously described animal model of MetS, obtained by feeding male rabbits ...